The influence of neutrophil elastase inhibitors on mice survival with the pancreatic cancer during experiment
Inhibitor neutrophil elastase (ZD0892) increases mice survival with the pancreatic cancer in experiment. This effect amplifies at application of ZD0892 with xelody (antimetabolite, antineoplastic drug, fluoropyrimidine carbamate derivative), which inhibits primary tumor growing in the pancreatic cancer.